Litcius/Paper detail

NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022

Douglas E. Wood, Ella A. Kazerooni, Denise R. Aberle, Abigail T. Berman, Lisa M. Brown, Georgie A. Eapen, David S. Ettinger, J. Scott Ferguson, Lifang Hou, Dipen Kadaria, Donald Klippenstein, Rohit Kumar, Rudy P. Lackner, Lorriana E. Leard, Inga T. Lennes, Ann N. Leung, Peter J. Mazzone, Robert E. Merritt, David E. Midthun, Mark W. Onaitis, Sudhakar Pipavath, Christie Pratt, Varun Puri, Dan J. Raz, Chakravarthy Reddy, Mary E. Reid, Kim L. Sandler, Jacob Sands, Matthew B. Schabath, Jamie L. Studts, Lynn Tanoue, Betty C. Tong, William D. Travis, Benjamin Wei, Kenneth D. Westover, Stephen C. Yang, Beth McCullough, Miranda Hughes

2022Journal of the National Comprehensive Cancer Network150 citationsDOIOpen Access PDF

Abstract

The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.

Topics & Concepts

MedicineLung cancer screeningLung cancerIntensive care medicineCancerLungOncologyMedical physicsInternal medicineLung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical Imaging
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022 | Litcius